Press release
Mantle Cell Lymphoma Therapeutics Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Mantle Cell Lymphoma Therapeutics Market Size
The increasing occurrence of mantle cell lymphoma is anticipated to drive the expansion of the mantle cell lymphoma therapeutics market. The disease is a type of non-Hodgkin lymphoma (NHL), a form of cancer that affects the lymphatic system. Mantle cell lymphoma therapeutics play a crucial role in minimizing the disease's spread by treating and managing its symptoms, thereby enhancing patient outcomes, extending survival rates, and lessening the burden of the disease. For instance, the National Library of Medicine, a US-based biomedical library run by the United States Federal Government, recorded in December 2022 that the yearly incidence of mantle cell lymphoma is one case per 200,000 individuals, accounting for 5% of all non-Hodgkin's lymphomas. Consequently, the increasing occurrence of mantle cell lymphoma is stimulating the mantle cell lymphoma therapeutics market's growth.
Get Your Mantle Cell Lymphoma Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report
What growth opportunities are expected to drive the mantle cell lymphoma therapeutics market's CAGR through 2034?
The market size for mantle cell lymphoma therapeutics has seen robust growth in the recent past. It is projected to expand from $2.42 billion in 2024 to $2.62 billion in 2025, marking a compound annual growth rate (CAGR) of 8.2%. This growth in the historic period is credited to progress in research, successful clinical trials, enhancement in diagnostic instruments, wider access to treatments, and cooperative research endeavors.
In the coming years, the market for therapeutics for mantle cell lymphoma is predicted to witness robust expansion, rising to "$3.56 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The anticipated growth for the forecast period can be tied to the progress in targeted therapies, the emergence of innovative immunotherapies, the rise in personalized medicine, global market proliferation, and a surge in the rate of incidence. Key trends anticipated over the forecast period encompass advancements in immunotherapy, the evolution of precision medicine and development of biomarkers, specific pathway targeted therapies, combined treatment approaches, and the incorporation of artificial intelligence (AI).
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
What are the emerging trends shaping the future of the mantle cell lymphoma therapeutics market?
An emerging trend in the mantle cell lymphoma therapeutics market is the rise of targeted therapy drugs. To maintain market dominance, key players in this sector are introducing new targeted therapy drugs. As an illustration, AstraZeneca plc., a pharmaceutical entity based in the UK, obtained approval to distribute their drug, Calquence (acalabrutinib) in China from the National Medical Products Administration (NMPA) by March 2023. This drug, Calquence (acalabrutinib), is a selective Bruton's tyrosine kinase (BTK) inhibitor purposed to offer an effective new treatment method that is well tolerated for the management of mantle cell lymphoma among adults.
Which growth-oriented segments of the mantle cell lymphoma therapeutics market are leading the industry's development?
The mantle cell lymphoma therapeutics market covered in this report is segmented -
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Subsegments:
1) By Combination Therapy: Chemotherapy Combinations, Targeted Therapy Combinations, Immunotherapy Combinations
2) By Monotherapy: Single-Agent Chemotherapy, Targeted Therapy Monotherapy, Immunotherapy Monotherapy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10813
What regions are leading the charge in the mantle cell lymphoma therapeutics market?
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2024. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What companies are at the forefront of innovation in the mantle cell lymphoma therapeutics market?
Major companies operating in the mantle cell lymphoma therapeutics market include AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
What Is Covered In The Mantle Cell Lymphoma Therapeutics Global Market Report?
• Market Size Forecast: Examine the mantle cell lymphoma therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the mantle cell lymphoma therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the mantle cell lymphoma therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the mantle cell lymphoma therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the mantle cell lymphoma therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the mantle cell lymphoma therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the mantle cell lymphoma therapeutics market.
• Competitive Landscape: Review strategic developments in the mantle cell lymphoma therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mantle Cell Lymphoma Therapeutics Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3893822 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
